Galectin Therapeutics Reports 2022 Financial Results and Provides Business Update
Go back to Galectin Therapeutics Reports 2022 Financial Results and Provides Business Update| GALECTIN (NASDAQ: GALT) | Delayed: 4.48 +0.31 (7.43%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.17 | 52 Week High | $3.05 | |||
| Open | $4.19 | 52 Week Low | $0.49 | |||
| Day High | $4.53 | P/E | N/A | |||
| Day Low | $4.19 | EPS | $-1.32 | |||
| Volume | 460,696 | |||||

